http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017060916-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7bf122e645f41977ad991f006775700 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_100f3b1e5b2b36b33149d49483ba6775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d20559c07bf47c69c47756248f87674 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6923 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 |
| filingDate | 2016-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb94d456b840f093dad0a388f5cc9ebd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caadd7a86e784990cd617943b691c765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a448ef62059e52f0cf539ceded2a07 |
| publicationDate | 2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017060916-A1 |
| titleOfInvention | Metallic nanoparticle alone and/or in combination as novel agent for the treatment of uncontrolled electric conductance related disorders and/or seizure, epilepsy & convulsions. |
| abstract | The present invention relates to pharmaceutical composition/s comprising of at-least one of metallic nanoparticles either alone or in their combinations, more preferably such metallic nanoparticles here may be of gold, silver and zinc nanoparticles; more particularly preferred if such composition may also contain at-least one of drugs from the category such as antiseizure, antiepileptic, antioxidants or nutraceuticals or other therapeutic class having potential to be use in such disorders, so that these compositions would be useful in therapeutic or prophylactic treatment as well as the management of pathophysiological or pathological states, arising either due to unregulated or unbalanced or dysregulated electrical conductance; such as (but not limited to) mainly convulsions and/or seizures and/or epilepsies etc. The present invention also discloses a more preferable synergistic and potentiating pharmaceutical composition; which may be combination of at-least one of metallic nanoparticles with the carbamazepine; more specifically to say such preferred metallic nanoparticles here may be gold, silver and zinc nanoparticles; as therapeutic or prophylactic treatment for the management of any pathophysiological or pathological states arising due to unregulated or unbalanced or dysregulated type of electric conductance disorders preferably such as convulsions, seizures or epilepsies. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019121748-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497717-B2 |
| priorityDate | 2015-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.